Bioidentical Hormones and Menopause: An Honest Look at the Evidence

If you're reading this, there's a decent chance you don't feel like yourself. The sleep is wrecked, the temperature regulation has its own agenda, the brain fog is real, and your interest in things you used to enjoy has quietly drained away. And somewhere along the line you've probably been handed one of two unsatisfying scripts: either "here, let me custom-formulate something special just for you," or "there's no evidence anything will help - this is just a normal phase." Both can leave you feeling unseen. Neither is the whole truth.

So here's a straight conversation about bioidentical hormones - what's real, what's marketing, and where the honest gaps are.

First, the word "bioidentical" is doing a lot of quiet work

"Bioidentical" simply means a hormone that's molecularly identical to the one your body already makes - for example, estradiol (a form of estrogen) or progesterone. It sounds like a meaningful category. The catch is that many FDA-approved, pharmacy-shelf hormones are already bioidentical. Estradiol patches, gels, and sprays, oral micronized estradiol, and micronized progesterone are all structurally identical to what your ovaries once produced. Some clinicians now call these "body-identical" to make the point.

The real distinction isn't bioidentical vs. synthetic. It's regulated vs. compounded.

Compounded bioidentical hormone therapy (you'll see it as "cBHT") is mixed by a compounding pharmacy and is not FDA-approved. That means it doesn't go through the same testing for dose accuracy, purity, and consistency from one batch to the next. So when a clinic markets "bioidentical hormones" as something you can only get through their special compounded formula, that's not quite right - you can get the same molecules in a product that's actually tested for what's in it. That's usually the safer place to start.

This isn't a fringe opinion. The American College of Obstetricians and Gynecologists, The Menopause Society, the Endocrine Society, and a 2020 review by the National Academies of Sciences all reach the same conclusion: there's no good evidence that compounded versions are safer or more effective than FDA-approved ones, and they shouldn't be the routine first choice when a regulated option exists. A few specifics are worth knowing:

• The idea that your dose can be precisely "customized" to a saliva or single blood test doesn't hold up well - hormone levels swing dramatically across a day and a cycle, especially in perimenopause, so there often isn't a stable number to dose against. We treat your symptoms and your risk profile, not a lab snapshot.
• Pellets deserve particular caution: they can push hormone levels well above the normal range, and once one is inserted, it can't be removed or dialed back if you have side effects. You're committed for months.

But here's the part most clinics won't say out loud

When you read "there's no evidence for that," it's worth knowing that the phrase hides three completely different situations:

1. We studied it, and it genuinely didn't work.
2. We never funded the study, so the answer is simply unknown.
3. We have good evidence it works - and the system still hasn't made it accessible.

Guidelines rarely tell you which one they mean. And the difference matters enormously, because situations 2 and 3 aren't scientific findings - they're choices about what our society decides is worth researching, teaching, and approving.

Here's the uncomfortable truth: we have systematically under-invested in studying what helps women and people in midlife feel better. Women were routinely excluded from clinical trials until federal rules required their inclusion in 1993, so the foundational evidence base for half the population is barely a generation old. Menopause is still under-taught in medical training - a minority of programs offer any structured curriculum on it. So when a guideline shrugs that there's "insufficient evidence" for a given symptom, that often means nobody ran the trial - not that the trial came back empty.

What makes this especially galling is that we've measured the cost of not treating far more rigorously than we've measured the treatments. Mayo Clinic researchers estimated that menopause symptoms cost roughly $1.8 billion a year in lost work time in the U.S. - and about $26.6 billion once medical costs are included. A Stanford study found that people who seek care for menopause symptoms earn around 10% less four years later. We can quantify the damage of leaving symptoms untreated down to the billion. We just haven't bothered to fund much research on relieving them.

What this means in practice (and a fair example: testosterone)

Take testosterone, which comes up often. For one specific concern - low sexual desire after menopause that's causing distress - there's actually solid, internationally endorsed evidence that testosterone can help. And yet, remarkably, there is no FDA-approved testosterone product designed for women anywhere on the market. That's not an evidence gap; that's the evidence existing and the system declining to build the product. For the other things people commonly hope testosterone will fix - energy, mood, mental clarity - the honest answer is that the research mostly hasn't been done at the quality needed to say much either way.

So what's the responsible thing to do with that honesty? Not to pretend the gap doesn't exist - and also not to treat the gap as a blank check to sell you whatever's trending. "We don't have a study" is a reason for humility and a real conversation; it is not, by itself, a reason to put you on an unproven, unregulated product. Both of those things are true at once, and holding both is exactly the point.

In our practice, that looks like: taking your symptoms completely seriously, being plain with you about what's well-established versus what's genuinely uncertain, starting with regulated options that we can actually stand behind, and making decisions with you rather than either dismissing you or upselling you.

So is there ever a place for compounded hormones?

Yes - as a tool for the gaps, not the default. Compounding makes real sense when you have a documented allergy or intolerance to an ingredient in every available FDA-approved option, or when you need a dose or form that simply isn't manufactured commercially. What we're cautious about is reaching for an untested, unregulated product first, when well-studied options exist and haven't been tried. That's a starting point, not a finish line.

The bottom line

You deserve better than the two bad scripts. You shouldn't be sold a mystery formula on the promise that it's secretly superior - and you shouldn't be told that because a study was never funded, your suffering isn't real or treatable. The truth lives in between: there are effective, well-studied options worth trying, there are honest uncertainties we'll name out loud, and there's a real conversation to be had about what fits your body, history, and goals.

If that's the kind of conversation you've been looking for, that's the kind we have.

Ready to talk it through with someone who'll take this seriously? Book a visit and let's figure out what actually fits.

This article is for general educational purposes and isn't a substitute for individualized medical care. Hormone therapy decisions depend on your personal health history and risk factors, and what's right varies from person to person. Please talk with a qualified clinician about your specific situation.